ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor ModelsCherrie K. Donawho, David J. Frost, Yan Luo et al.|Clinical Cancer Research|2007Cited by 770
Re-irradiation for malignant glioma: Toward patient selection and defining treatment parameters for salvageColette J. Shen, Lawrence Kleinberg, Syed Muhammad Usama et al.|Advances in Radiation Oncology|2018Cited by 37